日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell-Derived Hepatocytes for Cell-Based Therapy

符合现行良好生产规范的人类多能干细胞来源的肝细胞的细胞疗法验证

Samuel J I Blackford, Soon Seng Ng, Joe M Segal, Aileen J F King, Amazon L Austin, Deniz Kent, Jennifer Moore, Michael Sheldon, Dusko Ilic, Anil Dhawan, Ragai R Mitry, S Tamir Rashid